Calumet Specialty Products Partners (CLMT)

Basic Materials · Specialty Chemicals
$56.29 +0.14% on the day Market cap $4.9B 52-week range $17.42 to $59.87 Prices as of Oct 8, 2026

What the price implies

A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.

Free cash flow growth the price needs
24% a year for 10 years

At a market value of $4.9B, Calumet Specialty Products Partners's free cash flow of $57M (fiscal 2025) would need to grow about 24% a year for the stock to be worth today's price.

Assumes a 9% discount rate and 3% growth after year 10, on free cash flow (operating cash flow minus capital spending) from Calumet Specialty Products Partners's SEC filings. Change any assumption, or model revenue and margins instead, in the Modeling tab, or try your own numbers in the reverse DCF calculator.

Implied by the price24.4% a year
Free cash flow, last – years—
Revenue, same period-4.1% a year
Price to free cash flow86.5x

Fundamental grade

D

Five factors scored 1 to 9 from CLMT's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.

Valuation3
Profitability2
Growth9
Financial health1
Cash efficiency4

Results from SEC filings

Fiscal years, from Calumet Specialty Products Partners's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.

Fiscal year2022202320242025
Revenue$4.7B$4.2B$4.2B$4.1B
Net income-$173M$48M-$222M-$34M
Free cash flow-$436M-$287M-$123M$57M
EPS (diluted)——-$2.67-$0.39
Operating margin2.8%6.4%0.19%2.6%

Where the revenue comes from

Revenue by segments, fiscal 2025. Every breakdown, year by year.

Specialty Products and Solutions$2.7B64%
Montana/Renewables$1.2B29%
Performance Brands$312M7%

Superinvestors who own CLMT

From each investor's latest 13F filing (what a 13F shows). 2 of the investors we track hold it.

InvestorLast quarterValue% of portfolioQuarter
Cliff Asness
AQR Capital Management
New position $2M0.00%Q2 2026
Jay Petschek
Corsair Capital Management
New position $432,2400.05%Q2 2026

Insider buying

Open-market purchases by Calumet Specialty Products Partners's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.

No open-market insider purchases of CLMT in the last 12 months. Most insider activity is selling and option exercises, which aren't shown here.

Get an alert at your buy price

Pick the price you'd be interested at. We'll email you when CLMT trades at or below it.

$

New accounts get 7 days of Pro, price alerts included. No card needed.

In the full deep dive

DCF fair value per share
Yearly return (IRR) at today's price
Growth implied by revenue and margins
15+ years of statements and quarters

Questions

What growth does Calumet Specialty Products Partners's stock price imply?

At a market value of $4.9B, Calumet Specialty Products Partners would need its free cash flow to grow about 24% a year for 10 years (discounted at 9%, 3% growth after that) to be worth today's price.

Are Calumet Specialty Products Partners insiders buying the stock?

No open-market insider purchases of CLMT in the last 12 months, according to SEC Form 4 filings.

Which superinvestors own Calumet Specialty Products Partners?

2 of the superinvestors Investingly tracks hold CLMT in their latest 13F, including Cliff Asness, Jay Petschek.

Prices and ratios as of Oct 8, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.